Covid viral replication pathway
Featured in How to Draw the Coronavirus, the Paris Review, Rebekah Frumkin May 18, 2020
An mRNA vaccine, such as Moderna is testing, uses cell machinery to produce coronavirus spikes for the immune system to recognize and launch a defence against.
Celsion’s next generation vaccine initiative delivers, on a single plasmid, multiple SARS-CoV-2 antigens in conjunction with a potent immune modifier, interleukin-12 (IL-12), which directs a TH-1 immune response, stimulates T-cell immunity, and also promises the promotion of humoral immunity (antibody response). While most COVID-19 vaccines in late-stage clinical development are monovalent (S protein antigen only), Celsion has taken this multivalent approach in an effort to generate an even more robust immune response that not only results in a strong neutralizing antibody response, but also a more robust and durable T-cell response.
TheraPlas vaccine MOA_final_with_brushes
Cell membrane fat molecule
Cell membrane bilayer
Lenacapavir MOA
Establishment of the theca cell layer
HIV and the female genital tract
Mechanisms of CPA formation
Ovulatory follicle: Capillary growth
Lean or obese adipose tissue, inflammation
HIV viral replication
Hemoglobin
progression_of_IPF_CS6_25
DNA binding motif
Blood oxygen
Nerve structure
Multiple sclerosis
Immunity
Humoral immunity
Cell-Mediated immunity
Glut-4 transporter
Eukaryote vs prokaryote
DNA synthesis
DNA replication proteins, leading, lagging strands
DNA remodeling, transcription
DNA structure
DNA dimensions
DNA epigenetic mechanisms
DNA bonds
HIV-1 protease, an important target for pharmaceutical research
